InvestorsHub Logo
Followers 131
Posts 11471
Boards Moderated 0
Alias Born 01/06/2010

Re: someconcerns post# 894

Friday, 10/16/2015 7:33:56 AM

Friday, October 16, 2015 7:33:56 AM

Post# of 909
consensus as of a while back was around 35m 2015, 62M 2016, 148m 2018 rising to 300m in 2020.

I have not followed it real closely since it got absorbed into the behemoth that is Merck. the rumor, of course, is that Merck will hold the drug back to avoid the CVR payments...in my view that would be counterproductive. I sold everything out after the Cubist buyout was announced so I hold no CVRs

"Cellceutix reports Kevetrin meets all primary and secondary endpoints in Phase 1 study at Dana-Farber"